nang2
SENIOR MEMBER
- Joined
- Dec 14, 2015
- Messages
- 5,742
- Reaction score
- 2
- Country
- Location
UPDATE: Pfizer's oral COVID-19 antiviral cuts hospitalization, death by 89%, sending team barreling to FDA
Pfizer’s oral COVID-19 antiviral Paxlovid has cut the risk of | Pfizer’s oral COVID-19 antiviral has cut the risk of hospitalization or death by 89% in a late-phase trial, prompting the Big Pharma to stop the study and race to seek emergency use authorization from the FDA.
www.fiercebiotech.com
@Tai Hai Chen This may particularly interest you.